Chad N. White - Oct 3, 2022 Form 3 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Interim CFO
Signature
/s/ Chad N. White
Stock symbol
SNOA
Transactions as of
Oct 3, 2022
Transactions value $
$0
Form type
3
Date filed
10/12/2022, 05:03 PM
Next filing
Dec 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SNOA Stock Option (right to buy) Oct 3, 2022 Common Stock 5K $2.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer granted the options as an initial grant upon Mr. White's appointment as interim Chief Financial Officer of the Issuer. The options vest in three equal tranches annually on the grant date anniversary, beginning on October 3, 2023 and becoming fully vested on October 3, 2025, or upon change of control of the Issuer.